Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases (Q37204286)
Jump to navigation
Jump to search
scientific article published on 22 April 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases |
scientific article published on 22 April 2015 |
Statements
1 reference
Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases (English)
1 reference
John V Heymach
1 reference
Vivek Subbiah
1 reference
Jenny Berry
1 reference
Michael Roxas
1 reference
Nandita Guha-Thakurta
1 reference
Ishwaria Mohan Subbiah
1 reference
Siraj M Ali
1 reference
Caitlin McMahon
1 reference
Vincent Miller
1 reference
Tina Cascone
1 reference
Shobha Pai
1 reference
Zhenya Tang
1 reference
22 April 2015
1 reference
1 reference
76-79
1 reference
Identifiers
1 reference
1 reference
1 reference